Inventor
SPARKS RICHARD B
US66 patents
⚠️ This page may combine multiple inventors who share the name “SPARKS RICHARD B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INCYTE CORP
42 patentsUS8741895B2Jun 3, 2014
Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors
INCYTE CORP84 citations99
US8053433B2Nov 8, 2011
Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
INCYTE CORP107 citations99
US7335667B2Feb 26, 2008
Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as Janus kinase inhibitors
INCYTE CORP149 citations99
US9624241B2Apr 18, 2017
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP27 citations98
US9227985B2Jan 5, 2016
Tricyclic heterocycles as bet protein inhibitors
INCYTE CORP40 citations98
US9090611B2Jul 28, 2015
Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibitors
INCYTE CORP60 citations98
US8993605B2Mar 31, 2015
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP34 citations98
US8835423B2Sep 16, 2014
Azepine inhibitors of janus kinases
INCYTE CORP71 citations97
US8822511B2Sep 2, 2014
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP24 citations96
US10618910B2Apr 14, 2020
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP12 citations94
US10464947B2Nov 5, 2019
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP17 citations94
US10227359B2Mar 12, 2019
Tricyclic heterocycles as bet protein inhibitors
INCYTE CORP20 citations94
US10138248B2Nov 27, 2018
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors
INCYTE CORP36 citations94
US10092570B2Oct 9, 2018
Heterocyclylamines as PI3K inhibitors
INCYTE CORP17 citations94
US9938294B2Apr 10, 2018
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP24 citations94
US9834565B2Dec 5, 2017
Tricyclic heterocycles as bet protein inhibitors
INCYTE CORP23 citations94
US9730939B2Aug 15, 2017
Heterocyclylamines as PI3K inhibitors
INCYTE CORP23 citations94
US9527864B2Dec 27, 2016
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP31 citations94
US9527848B2Dec 27, 2016
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
INCYTE CORP25 citations94
US9309251B2Apr 12, 2016
Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
INCYTE CORP25 citations94
US9290514B2Mar 22, 2016
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP33 citations94
US10646492B2May 12, 2020
Heterocyclylamines as PI3K inhibitors
INCYTE CORP9 citations93
US10376513B2Aug 13, 2019
Heterocyclylamines as PI3K inhibitors
INCYTE CORP12 citations93
US10034864B2Jul 31, 2018
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP8 citations93
US9944646B2Apr 17, 2018
Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
INCYTE CORP16 citations93
US9815839B2Nov 14, 2017
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
INCYTE CORP20 citations93
US9789094B2Oct 17, 2017
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP11 citations93
US9580419B2Feb 28, 2017
Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as Janus kinase inhibitors
INCYTE CORP10 citations93
US9320732B2Apr 26, 2016
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP14 citations93
US8951536B2Feb 10, 2015
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
INCYTE CORP25 citations92
US8377976B2Feb 19, 2013
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
INCYTE CORP24 citations89
US7141596B2Nov 28, 2006
Inhibitors of proteins that bind phosphorylated molecules
INCYTE CORP24 citations89
US10919912B2Feb 16, 2021
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP10 citations86
US11498926B2Nov 15, 2022
Tricyclic heterocycles as BET protein inhibitors
INCYTE CORP4 citations84
US11433071B2Sep 6, 2022
Heterocyclylamines as PI3K inhibitors
INCYTE CORP3 citations84
US10975088B2Apr 13, 2021
Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors
INCYTE CORP6 citations84
US10738057B2Aug 11, 2020
Tertiary alcohols as PI3K-γ inhibitors
INCYTE CORP5 citations84
US10653677B2May 19, 2020
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP4 citations84
US10479795B2Nov 19, 2019
Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors
INCYTE CORP13 citations84
US10472368B2Nov 12, 2019
Heterocyclic compounds as PI3K-γ inhibitors
INCYTE CORP12 citations84
US10369137B2Aug 6, 2019
1,2,5-Oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
INCYTE CORP5 citations84
US10259818B2Apr 16, 2019
Bicyclic azaheterocyclobenzylamines as PI3K inhibitors
INCYTE CORP12 citations84
COMBS ANDREW P
5 patentsUS8088803B2Jan 3, 2012
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
COMBS ANDREW P64 citations99
US8759359B2Jun 24, 2014
Substituted heteroaryl fused derivatives as PI3K inhibitors
COMBS ANDREW P64 citations98
US9193721B2Nov 24, 2015
Fused derivatives as PI3Kδ inhibitors
COMBS ANDREW P26 citations92
US8796319B2Aug 5, 2014
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
COMBS ANDREW P21 citations92
US8450351B2May 28, 2013
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
COMBS ANDREW P18 citations91
RODGERS JAMES D
1 patentLI YUN-LONG
1 patentARVANITIS ARGYRIOS G
1 patentShowing the top 50 of 66 patents by PatentIndex Score.